Company Quick10K Filing
Quantrx Biomedical
10-Q 2021-03-31 Filed 2021-05-17
10-K 2020-12-31 Filed 2021-04-15
10-Q 2020-09-30 Filed 2020-11-17
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-20
10-K 2019-12-31 Filed 2020-04-14
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-15
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-12-02
10-Q 2016-06-30 Filed 2016-08-17
10-Q 2016-03-31 Filed 2016-05-20
10-K 2015-12-31 Filed 2016-04-13
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-17
10-Q 2015-03-31 Filed 2015-07-22
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-18
10-Q 2014-06-28 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-20
10-K 2013-12-31 Filed 2014-04-14
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-20
10-K 2012-12-31 Filed 2013-04-15
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-05-21
10-K 2011-12-31 Filed 2012-04-17
10-Q 2011-09-30 Filed 2011-11-18
10-Q 2011-06-30 Filed 2011-08-16
10-Q 2011-03-31 Filed 2011-05-20
10-K 2010-12-31 Filed 2011-04-14
10-Q 2010-09-30 Filed 2010-11-19
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-31

Quantrx Biomedical Financials

QTXB Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-282014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash1231811191052141216625421918921484613647135339460403401401322282201155
Accounts Receivable2444262310100000000
Inventory333333322222100
PP&E443935353127444433322221111000000000
Assets5876245865745706104744734384293984673725514914374513963593222792222132372251901,3911,3221,2011,111582531440384
Accounts Payable14418722324326532437537835837628530637840746247446841912212314315316115816717116815714915249585851
Long-Term Debt444444444444444444444444444444414141391,6391,6931,580361,67338390
Liabilities3144264515526687878548949199711,0881,3001,3101,5411,7051,7511,7521,7731,7911,8271,8921,8001,8912,0082,0872,1112,1402,1762,2182,1052,0882,1502,1562,200
Stockholders' Equity27319813522-98-177-380-420-480-542-690-834-938-990-1,215-1,315-1,302-1,377-1,432-1,505-1,614-1,578-1,678-1,771-1,863-1,921-750-855-1,017-993-1,506-1,626-1,716-1,816
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-282014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2445362311111110000000000
Cost of Revenue
Gross Profit
R&D1315-707144122056163014130000000
SG&A371652195412471759142740511317952253601821132222271717285914231716
Tax000000000000000000000000000000000
Net Income-139-286-189-218-163-148-4123-62-157-184-260-158-225-213-54-110-91-73-108-116-100-93-68-661,120-105-14324-112-97-100
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-282014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-35-69-46-95-17-24-42-50-31-27-50-84-93-65-65-25-114-22-25-31-11-27-39-26-25-60-57-92-20-40-81-46
Cash Investing00-50000203030303030300-5000000000497000000
Cash Financing5545459515372700136025003635-20-11520742400-61000